1-{[(E)-2-phenylvinyl]sulfonyl}piperidine-4-carboxylic acid, 95.0%, 5g

N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-ylamino)phenyl)acetamide, 97%, 250mg

Benzyl(3S)-3-hydroxyazepane-1-carboxylate, 98%, 1g

1-Bromo-3-methoxy-5-(trifluoromethyl)benzene, 95.0%, 10g

3-(4-(2-Aminoethyl)phenyl)propanoic acid hydrochloride, 95%, 100mg

1-(Methylsulfonyl)piperidin-3-amine hydrochloride, 98%, 50mg

(R)-N-Benzyl-2-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)-N,3,3-trimethylbutanamide, 97%, 100mg

ETHYL 2-(4-FLUORO-3-NITROPHENYL)ACETATE, 95.0%, 1g

1-methyl-4-nitro-1H-pyrazole-3-carbohydrazide, 250mg

Lámina de cobre (OFHC) 99,99% 0,1 x 100 x 100 mm 1 ud.

Ethyl 1-cyanocyclohexane-1-carboxylate, 98%, 1g

(4-Cyano-2-methylphenyl)boronic acid, 95.0%, 25g

(R)-3-(4-acetylphenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 98%, 1g